Fallopian tube precursors of ovarian low- and high-grade serous neoplasms
KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma
Low-grade serous carcinoma: new concepts and emerging therapies
PAX2 Expression in Ovarian Cancer
Poor survival with wild-type TP53 ovarian cancer?
Survival in women with grade 1 serous ovarian carcinoma
Previous
Previous
2014
Next
Next